Found 10 matching trials
An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML) PHASE1 The purpose of the study is to assess how AZD1152 is absorbed or excreted i...
Show More Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants. PHASE1 This is a Phase I/II clinical study to determine the maximum tolerated dose...
Show More Learn More & Join Trial
Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia PHASE1 The purpose of this study is to assess safety and tolerability of multiple ...
Show More Learn More & Join Trial
AZD1152 in Diffuse Large B-cell Lymphoma PHASE1 Diffuse large B-cell lymphoma is the commonest type of aggressive non-Hodgk...
Show More Location
Christie NHS Foundation Trust (Christie Hospital)
Learn More & Join Trial
AZD1152 in Patients With Advanced Solid Malignancies-Study 3 PHASE1 The primary purpose of this protocol is to investigate the safety and toler...
Show More Learn More & Join Trial
AZD1152 in Patients With Advanced Solid Malignancies-Study 1 PHASE1 The primary purpose of this protocol is to investigate the safety and toler...
Show More Learn More & Join Trial
AZD1152 in Patients With Advanced Solid Malignancies PHASE1 The primary purpose of this protocol is to investigate the safety and toler...
Show More Learn More & Join Trial
Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients PHASE2 The purpose of this study is to assess the efficacy, safety and tolerabilit...
Show More Learn More & Join Trial
Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC) PHASE1 A study to assess the safety and tolerability of AZD1152 in combination wit...
Show More Learn More & Join Trial
Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML) PHASE1 The purpose of this study is to assess safety and tolerability of multiple ...
Show More Learn More & Join Trial